172 related articles for article (PubMed ID: 28581638)
1. Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.
Kim HS; Rotundo L; Yang JD; Kim D; Kothari N; Feurdean M; Ruhl C; Unalp-Arida A
J Viral Hepat; 2017 Nov; 24(11):1052-1066. PubMed ID: 28581638
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey.
Ioannou GN
Ann Intern Med; 2011 Mar; 154(5):319-28. PubMed ID: 21357909
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HBV Infection, Vaccine-Induced Immunity, and Susceptibility Among At-Risk Populations: US Households, 2013-2018.
Roberts H; Ly KN; Yin S; Hughes E; Teshale E; Jiles R
Hepatology; 2021 Nov; 74(5):2353-2365. PubMed ID: 34097776
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and immunizations among Asian American college students: infection, exposure, and immunity rates.
Lee H; Kiang P; Watanabe P; Halon P; Shi L; Church DR
J Am Coll Health; 2013; 61(2):67-74. PubMed ID: 23409856
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection.
Yeo YH; Le MH; Chang ET; Henry L; Nguyen MH
Hepatology; 2019 Apr; 69(4):1385-1397. PubMed ID: 30246260
[TBL] [Abstract][Full Text] [Related]
6. Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016.
Le MH; Yeo YH; Cheung R; Henry L; Lok AS; Nguyen MH
Hepatology; 2020 Feb; 71(2):431-443. PubMed ID: 31228279
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.
Roberts H; Kruszon-Moran D; Ly KN; Hughes E; Iqbal K; Jiles RB; Holmberg SD
Hepatology; 2016 Feb; 63(2):388-97. PubMed ID: 26251317
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis B virus infection in the United States in the era of vaccination.
Wasley A; Kruszon-Moran D; Kuhnert W; Simard EP; Finelli L; McQuillan G; Bell B
J Infect Dis; 2010 Jul; 202(2):192-201. PubMed ID: 20533878
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.
Olayinka AT; Oyemakinde A; Balogun MS; Ajudua A; Nguku P; Aderinola M; Egwuenu-Oladejo A; Ajisegiri SW; Sha'aibu S; Musa BO; Gidado S; Nasidi A
Am J Trop Med Hyg; 2016 Oct; 95(4):902-907. PubMed ID: 27527630
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
[TBL] [Abstract][Full Text] [Related]
11. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
[TBL] [Abstract][Full Text] [Related]
14. A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.
Ji Z; Wang T; Shao Z; Huang D; Wang A; Guo Z; Long Y; Zhang L; Su H; Zhang Q; Yan Y; Fan D
PLoS One; 2014; 9(5):e97474. PubMed ID: 24832483
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
16. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
17. Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
Klinger G; Chodick G; Levy I
Vaccine; 2018 Apr; 36(17):2288-2292. PubMed ID: 29573878
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review.
Ang LW; Cutter J; James L; Goh KT
Vaccine; 2013 Dec; 32(1):103-10. PubMed ID: 24200974
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.
Di Lello FA; Blejer J; Alter A; Bartoli S; Vargas F; Ruiz R; Galli C; Blanco S; Gallego S; Fernández R; Martínez AP; Flichman DM
Vaccine; 2020 Mar; 38(12):2678-2682. PubMed ID: 32061386
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
Murhekar MV; Santhosh Kumar M; Kamaraj P; Khan SA; Allam RR; Barde P; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Girish Kumar CP; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
Int J Infect Dis; 2020 Nov; 100():455-460. PubMed ID: 32896662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
